FDA Investigator Virgilio F Pacio, CSO

Virgilio F Pacio, CSO has inspections in 6 countries as of 13 Oct 2023. Virgilio F Pacio, CSO has collaborated with a combinined 8838 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
302
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Germany, Canada, Italy
Co-Investigator(s):
Aaron J Adler, Adam R Cooke, Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Albert C Cheng, Alexandra B Pitkin, Alexandria L Capuano, Allen F Hall, Allison A Rodriguez, Alyson C Tanner, Amalia C Himaya, Amanda L Fyles, Amanda N Schaupp, Amir Alavi, Ana M Pietsch, Anastasia M Shields, Anderson, Andrea A Branche, Andrew K Haack, PhD, Andrew Le, Andrew S Limson, Andrews, Andy B Lee, Angela Shepas, Angele C Smith, Angelina M Albert, Anh M Lac, Anita Narula, PhD, Ann L Demarco, Ann Marie Montemurro, Anthony G Emerson, Arie C Menachem, Arsen Karapetyan, Arthur S Williams, Jr, Ashar P Parikh, Ashley N Queen, PhD, Astrida B Mattson, Ayodele I Ojediran, Azza Talaat, Babajide Michael Osunsanmi, Beverly A Thomas, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonnie I Needleman, Bowman, Brandon L Blakely, Brenda L Reihing, Brenda W Uratani, PhD, Brian J Ryan, Brian P Putz, Brien C Fox, Bryan A Galvez, Bryan L Mcguckin, Bush, Calvin B Koerner, Candace Y Gomez Broughton, Carla J Lundi, Carlos Chavez, Carolina D Vasquez, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Catherine J Laufmann, Cathryn M Groehnert, CDR Cecily Jones, Cecilia H Kieu, Celena Ngo, Celeta S Coves, Charles L Larson, Chelsea N Sealey, Cheryl D Mccall, Christina D Mello, Christine I Shaw, Christopher D Washington, Christopher Downey, PhD, Christopher M Hernandez, Christopher M Jenner, Christopher M Reed, Christopher R Czajka, Claire M Minden, Claudia Mperez Kasmarski, Comyar Shoghi, Courtney N Long, Crystal Monroy, Cynthia F Kleppinger, MD, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia L Gorveatt, Dan G Eisenbrey, Daniel J Lahar, Daniel J Roberts, Daniel R Solis, Darren S Brown, Darrin E Davis, Daryl A Dewoskin, David G Whitman, David Serrano, Davis, Dawn E Barkans, Deborah A Greco, Deborah W Hsu, Debra J Fracassa, Dejon N Harris, Desiree C Iya, Diana M Rand, Diane Cvan Leeuwen, Diane L Raccasi, Diane R Weidley, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Donna Mwilliams Hill, Douglas J Scott, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Dyana K Stone, Edwin Melendez, Eileen A Liu, Elaine A Bunch, Elaine S Chow, Eliezar Ramos, Elizabeth A Girard, Elizabeth Ad Girard, Elizabeth Ll Edwards, Emmanuel B Diric, Erika V Butler, Esther B Gamallo Herrera, Esther Bgamello Herrera, Eugene Y Chang, Evelyn Wong, Farhana Khan, Felix Maldonado, Finn A Slizza, Francis J Eng, Francisco, Freddy Ortiz Colon, Frederick Fricke, Frederick L Fricke, Gabriel Guevarra, Gabriel M Guevarra, Gam S Zamil, Garrad R Poole, Gavin T Cua, Gene D Arcy, Geoffrey M Leist, Geraldine H Matining, Geraldine M Peregrin, Gilbert T Salud, Grace Deneke, Greg K Keshishyan, Gregory A Berg, Hei Chi Siu, Heidy C Perales, Heika R Tait, Helen B Ricalde, Herminio C Francisco, Himanshu Gupta, PhD, Hinh T Nguyen, Hoover, Hossein Khorshidi, PhD, Iris C Macinnes, Jacob W Reynolds, Jade A Rorberg, Jai P Singh, James A Barreto, James A Lane, James B Arnett, James M Timper Jr, James P Stumpff, James R Fleckenstein, Jamie M Du, Jane S Wernberg, Janet Blount, Janet D Bart, Janet Pulver, Jasmine N Thompson, Jeff M Uriarte, Jeffery A Johnson, Jeffrey D Sloan, Jeffrey P Raimondi, Jennie J Fan, Jennifer L Gustavus, Jennifer M Gogley, Jenny L Chisem, Jenny L Mccardell, Jeremy Beber, Jeremy H Nguyen, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joel D Hustedt, Joey V Quitania, Jogy George, John A Gonzales, John A Gonzalez, John A Iwen, John Cheng (NMI), John D White, John L Stevens, John P Jorgensen, Jolanna A Norton, Jose E Melendez, DDC, Joseph C Yen, Joseph X Philips, Joseph X Phillips, Joshua E Yao, Juan J Casado, Juanita Banuelos, Juanj Wu, Judy C Nepsa, Julia E Chervoni, Julie A Rorberg, Julie A Stocklin, Julie D Bringger, Julie Rorberg, Justine Tomasso, Ka L Wong, Kaarin M Slotte, Kalavati Suvarna, PhD, Karen A Wolnik, Karen L Bauer, Karen P Langer, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kathy Chiu, Kathy Kuo, Keith P Iams, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kevin A Gonzalez, Kevin N Tran, Kevin T Gerrity, Kham Phommachang, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kim Thomas Chase, Kimberly M Lichter, Kine Thomas Cruse, Kirtida Patel, Kurt A Brorson, PhD, Lakecha N Lewis, Langer, Lanita F Kelley, Lata C Mathew, PhD, Laurimer Kuilan Torres, Laurissa S Flowers, Lavender M Huskey, Leeterry Moore, Leonard H Lavi, Lestine C Webb, Lewisjess, Liatte Kreuger, PharmD, Lillian S Wu, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda L Ng, Linda S Leja, Linda Thai, Linda Than, Ling Yul Liu, Lisa Shin, Lori J Silverstein, Louis B Cencetti, Louise B Cencetti, LT Richard A Lyght, Lucas B Leake, M Jasnethoson Thompson, Marcellinus D Dordunoo, Marcia B Williams, Marco S Esteves, Marcus F Yambot, Margaret M Sands, Maria C Agpaoa, Maria C Fermin, Marianela Aponte Cruz, Marie Falcone, Marie T Falcone, Marijo B Kambere, PhD, Mariza M Jafary, Mariza M Jalary, Mark A Tucker, Mark Brunswick, PhD, Mark C Saale, Mark W Babbitt, Mary E Storch, Mary Ewilkerson Brinsko, Marybet Lopez, Matthew B Casale, Matthew J Johnson, Matthew R Clabeaux, Maurice M Sheehan, Maxyne Lam, Maxyne T Lam, Megan A Haggerty, Mei Chi Siu, Mei Siu, Michael D Garcia, Michael R Goga, Michael S Araneta, Michael S Aranota, Michael Shanks, MS, Michael T Cyrus, Michele R Douglas, Michelle A Mash, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmind, Mihaly S Ligmond, Mikel T Wright, Milos Dokmanovic, PhD, Minh D Phan, Monica Commerford, PhD, Monica J Wilkins, Mra Davism, Mra Munizn, Muralidhara B Gavini, PhD, Nabeela J Chaudhry, Nancy E Byerly, Nancy E Smith, Nancy L Rolli, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Nayan J Patel, Nelly N Tran, Nianna C Burns, Nicholas L Hunt, Omotunde O Osunsanmi, Pabhu P Raju, Patricia F Alberico, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul E Stein, Paul F Rader, Paul M Kawamoto, Paul R Whitby, Paula A Trost, Peter C Chow, Peter E Baker, Phal K Chhun, Philip F Istafanos, DMV, MS, Phillip L Toy, Prabhu P Raju, Qing Joanna Zhou, PhD, Rabin N Ghoshal, Rachel C Harrington, Rachel C Stanton, Ralph Jerndal, Randall N Johnson, Randy L Self, Raymond T Oji, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard A Abate, Richard C Chiang, Richard K Vogel, Richard Ledwidge (nmi), PhD, Richard W Berning, Richard W Tubb, Richmond K Yip, Robert C Coleman, Robert C Hoover, Robert D Tollefsen, Robert S Sweeton, Robert T Lorenz, Robert W Jennings, Rochelle A Rolnik, Rodney D Combs, Roger F Zabinski, Rose M Ashley, Rowena S Nguyen, Rumany C Penn, PharmD, Ruth A Williams, Ryan J Borges, S Lori Brown, PhD MPH, Saied A Asbagh, Samuel K Gibbons, Jr, Sandra L Shire, DMD, MPA, Sandra S Saniga, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Sara Jdent Acosta, Sarah A Hassas, Scott K Zika, Scott N Lim, Sean M Tessicini, Sean P Desbrow, Selene T Torres, Shannon B Ruelle, Shaquenta Y Perkins, Shaquenta Yperkinsliming Zhang, Sharon I Gundersen, Sharon K Thoma, PharmD, Shelley H Beausoleil, Sheri L Stephenson, Sidonie J Takougang, Sonia R Peterson, Sonya L Karsik, Sparky L Bartee, Srinivas R Chennamaneni, PhD, State Agency, Stephanie A Slater, MS, Stephen C Smith, Stephen D Brown, Stephen R Souza, Steven E Porter, Jr, Sudipan Karmakar, Sue Lee Chan, Sumit Sen, Sundy V Sedwick, Sundy Ven, Sunita Masson, Sunita Vij, Susan F Laska, MS, Susanna E Ford, Analyst, Susant Hadman, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamil Arasu, PhD, Tammy Vasquez Hancock, Tania Y Hall, Tara L Stockton, Tawny L Colling, Teresa I Navas, Teresa T Cain, Terrance L Thomas, Terrance P Nguyen, Terri L Dodds, Terri L Jones, Thanh M Andrews, Thao T Kwan, Thao X Tran, That T Kwan, Theresa Kirkham (NMI), Thomas J Arista, Thomas R Beilke, Thuy T Nguyen, LCDR, Tiara M Brown, Timothy P Lafave, Timothy T Kapsala, Tomika L Bivens, Tony J Wu, Tracey T Duong, Travis S Bradley, Trudy R Papson, Truong Xuan Nguyen (Andy), Trushani T Desai, Tsedenia Woldehanna, Tuan A Nguyen, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie L Whipp, Vashti E Bocker, Veronica Fuentes, MS, Vickie L Anderson, Vien Q Le, Vioela J Caze, Virginia Carroll, PhD, Walden H Lee, Walden Lee, Walter N Lange, Wayne E Seifert, William J Leonard, Wr Bowman, Xiaohui Shen, Yanming An, PhD, Yasamin Ameri, Yehualashet A Gessesse, Yen Tso Kuo, Yi Lin, Yi Wang, PhD, Youkeun Kim, Yumi J Hiramine, Yvette E Elacio, Yvette E Guillermo, Yvette Mlacour Davis, Yvins Dezan, Yvonne C Wilkes, Yvonne T Lacour, Yvonne Y Wu, Zachary A Bogorad, Zachary L Miller, Zerita White, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Ziyang Su, PhD

Virgilio F Pacio, CSO's Documents

Publish Date Document Type Title
January, 2013 EIR University of California Medical Center - EIR, 2013-01-15
October, 2004 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2004-10-26
August, 2013 FDA 483 Infantino LLC - Form 483, 2013-08-07
November, 2006 FDA 483 Southwood Pharmaceuticals Inc - Form 483, 2006-11-15
August, 2010 FDA 483 Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs - Form 483, 2010-08-06
August, 2015 FDA 483 ADAMSON ANALYTICAL LABORATORIES INC - Form 483, 2015-08-14
March, 2016 EIR Prometheus Laboratories Inc. - EIR, 2016-03-25
November, 2011 FDA 483 Carlsbad Technology, Inc. - Form 483, 2011-11-17
May, 2012 FDA 483 Societal CDMO San Diego, LLC - Form 483, 2012-05-11
May, 2015 FDA 483 Vista Biologicals Corporation - Form 483, 2015-05-06
June, 2013 FDA 483 International Medication Systems, Ltd. - Form 483, 2013-06-17
April, 2008 FDA 483 Cosway Company, Inc. - Form 483, 2008-04-15
February, 2007 FDA 483 PRESTIGE COSMETICS, INC. - Form 483, 2007-02-22
February, 2012 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2012-02-23
July, 2001 EIR Defender SD Manufacturing LLC - EIR, 2001-07-05
January, 2012 FDA 483 Bachem Americas, Inc. - Form 483, 2012-01-20
September, 2006 EIR Aaron Thomas Company Inc - EIR, 2006-09-20
March, 2015 EIR Spectrum Pharmaceuticals, Inc. - EIR, 2015-03-31
March, 2001 FDA 483 Ionis Pharmaceuticals Inc. - Form 483, 2001-03-15
April, 2012 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2012-04-16
October, 2000 FDA 483 Response Apotex Pharmachem Inc. - Form 483R, 2000-12-11
May, 2003 FDA 483 ALS Group USA, Corp. - Form 483, 2003-05-29
October, 2004 EIR Alliance Medical Products, Inc. (dba Siegfried Irvine) - EIR, 2004-10-26
December, 2006 FDA 483 Private Label Partners, Inc. - Form 483, 2006-12-18
February, 2000 EIR Teva Parenteral Medicines, Inc. - EIR, 2000-02-25
April, 2004 FDA 483 PRESTIGE COSMETICS, INC. - Form 483, 2004-04-14
January, 2009 FDA 483 HRC Laboratories Inc. - Form 483, 2009-01-23
January, 2016 FDA 483 Respironics California, LLC - Form 483, 2016-01-15
September, 2014 EIR Aurora Medbiochem Company - EIR, 2014-09-04
February, 2004 EIR Defender SD Manufacturing LLC - EIR, 2004-02-24
December, 2000 FDA 483 Tera Pharmaceuticals Inc - Form 483, 2000-12-08
September, 2002 EIR Defender SD Manufacturing LLC - EIR, 2002-09-20
June, 2016 FDA 483 Apotex Pharmachem India Pvt. Ltd. - Form 483, 2016-06-03
September, 2002 FDA 483 Response Defender SD Manufacturing LLC - Form 483R, 2002-09-26
October, 2011 FDA 483 Societal CDMO San Diego, LLC - Form 483, 2011-10-21
February, 2001 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2001-02-21
January, 2012 EIR Bachem Americas, Inc. - EIR, 2012-01-20
May, 2010 EIR Teva Parenteral Medicines, Inc. - EIR, 2010-05-14
July, 2001 FDA 483 Response Defender SD Manufacturing LLC - Form 483R, 2001-07-27
October, 2000 EIR Apotex Pharmachem Inc. - EIR, 2000-10-04
August, 2010 FDA 483 Blaine Labs Inc. - Form 483, 2010-08-12
August, 2002 FDA 483 Response Best Formulations Inc. - Form 483R, 2002-11-21
September, 2014 FDA 483 Aurora Medbiochem Company - Form 483, 2014-09-04
April, 2002 FDA 483 H J Harkins Company Inc. - Form 483, 2002-04-18
January, 2002 FDA 483 Carlsbad Technology, Inc. - Form 483, 2002-01-15
July, 2004 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2004-07-16
August, 2015 FDA 483 Response ADAMSON ANALYTICAL LABORATORIES INC - Form 483R, 2015-08-25
January, 2013 FDA 483 University of California Medical Center - Form 483, 2013-01-15
July, 2016 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2016-08-19
May, 2001 EIR Watson Laboratories, Inc. - EIR, 2001-06-06
July, 2016 EIR Teva Parenteral Medicines, Inc. - EIR, 2016-07-29
August, 2006 FDA 483 Altura Pharmaceuticals Inc - Form 483, 2006-08-28
June, 2010 FDA 483 PolyPeptide Laboratories San Diego LLC - Form 483, 2010-06-28
February, 2013 FDA 483 PlusPharma, Inc. - Form 483, 2013-02-28
May, 2014 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2014-05-30
August, 2009 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2009-08-19
November, 2006 FDA 483 Soaptronic LLC. - Form 483, 2006-11-28
May, 2015 FDA 483 Response Genentech, Inc. - Form 483R, 2015-06-12
April, 2014 FDA 483 Amarc Enterprises, Inc. - Form 483, 2014-04-10
July, 2001 FDA 483 Prima Pharm, Inc. - Form 483, 2001-07-05
February, 2014 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2014-02-10
January, 2010 FDA 483 ALS Group USA, Corp. - Form 483, 2010-01-28
January, 2004 FDA 483 Chemica - Form 483, 2004-01-30
February, 2008 FDA 483 Andrew M Martin Co Inc - Form 483, 2008-02-04
November, 2013 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2013-11-15
November, 2006 FDA 483 Spatz Corp Dba Spatz Laboratories - Form 483, 2006-11-08
March, 2013 EIR Pacira Pharmaceuticals, Inc. - EIR, 2013-03-27
February, 2011 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2011-02-14
January, 2006 EIR Expert Chemical Analysis, Inc. - EIR, 2006-01-25
June, 2000 EIR B. Braun Medical Inc. - EIR, 2000-06-30
July, 2015 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2015-07-22
June, 2004 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2004-06-10
November, 2002 FDA 483 Polypeptide Laboratories Inc - Form 483, 2002-11-27
September, 2015 FDA 483 GRAM Laboratories, Inc. - Form 483, 2015-09-04
February, 2016 FDA 483 Eurofins Advantar Laboratories, Inc. - Form 483, 2016-02-03
March, 2008 FDA 483 Synergy Health AST, LLC - Form 483, 2008-03-26
November, 2013 EIR Ajinomoto Althea, Inc. - EIR, 2013-11-15
April, 2012 EIR PYRAMID Laboratories, Inc. - EIR, 2012-04-26
March, 2013 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2013-03-27
November, 2000 FDA 483 S&B Pharma LLC dba Norac Pharma - Form 483, 2000-11-06
November, 2011 EIR Carlsbad Technology, Inc. - EIR, 2011-11-17
August, 2006 FDA 483 Capco Custom Packaging Inc - Form 483, 2006-08-15
October, 2002 EIR Bachem Americas, Inc. - EIR, 2002-10-11
May, 2015 EIR Genentech, Inc. - EIR, 2015-05-21
August, 2002 EIR Best Formulations Inc. - EIR, 2002-08-07
November, 2002 EIR Ionis Pharmaceuticals Inc. - EIR, 2002-11-05
November, 2014 FDA 483 Carlsbad Technology, Inc. - Form 483, 2014-11-21
May, 2001 FDA 483 Watson Laboratories, Inc. - Form 483, 2001-05-17
January, 2005 EIR Ajinomoto Althea, Inc. - EIR, 2005-01-26
February, 2004 FDA 483 Defender SD Manufacturing LLC - Form 483, 2004-02-24
July, 2016 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2016-07-29
January, 2001 EIR Mallinckrodt Inc - EIR, 2001-01-23
February, 2006 FDA 483 CATALENT SAN DIEGO, INC. - Form 483, 2006-02-23
February, 2000 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2000-02-25
April, 2006 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2006-04-03
March, 2007 FDA 483 McGuff Pharmaceuticals, Inc. - Form 483, 2007-03-23
November, 2001 FDA 483 B. Braun Medical Inc. - Form 483, 2001-11-20
September, 2013 FDA 483 Strata Skin Sciences, Inc. - Form 483, 2013-09-24
March, 2008 FDA 483 Response Noven Pharmaceuticals, Inc. - Form 483R, 2008-04-03
February, 2006 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2006-02-23
May, 2015 FDA 483 Genentech, Inc. - Form 483, 2015-05-21
November, 2014 FDA 483 Bachem Americas, Inc. - Form 483, 2014-11-07
September, 2002 FDA 483 Defender SD Manufacturing LLC - Form 483, 2002-09-20
June, 2009 FDA 483 Vege-Kurl Inc - Form 483, 2009-06-11
July, 2007 FDA 483 Anacapa Technologies, Inc - Form 483, 2007-07-23
October, 2002 FDA 483 Bachem Americas, Inc. - Form 483, 2002-10-11
May, 2010 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2010-05-07
August, 2002 FDA 483 Best Formulations Inc. - Form 483, 2002-08-07
August, 2013 FDA 483 Bausch & Lomb Incorporated - Form 483, 2013-08-23
October, 2012 FDA 483 PolyPeptide Laboratories San Diego LLC - Form 483, 2012-10-16
January, 2011 FDA 483 Expert Chemical Analysis, Inc. - Form 483, 2011-01-28
March, 2008 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2008-03-20
July, 2004 EIR Amphastar Pharmaceuticals, Inc. - EIR, 2004-07-16
October, 2003 FDA 483 Response Weber Laboratories Inc - Form 483R, 2003-10-29
June, 2011 FDA 483 Bachem Americas, Inc. - Form 483, 2011-06-02
November, 2001 EIR B. Braun Medical Inc. - EIR, 2001-12-18
July, 2003 FDA 483 Nexgen Pharma, Inc. - Form 483, 2003-07-29
July, 2006 FDA 483 Levlad, LLC - Form 483, 2006-07-18
March, 2015 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2015-03-31
March, 2001 EIR Ionis Pharmaceuticals Inc. - EIR, 2001-03-15
November, 2007 FDA 483 Sterigenics Radiation Technologies, LLC - Form 483, 2007-11-08
July, 2002 FDA 483 PRESTIGE COSMETICS, INC. - Form 483, 2002-07-01
July, 2009 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2009-07-10
November, 2014 EIR Carlsbad Technology, Inc. - EIR, 2014-11-21
February, 2011 FDA 483 Response Noven Pharmaceuticals, Inc. - Form 483R, 2011-02-28
February, 2001 EIR Teva Parenteral Medicines, Inc. - EIR, 2001-02-14
October, 2003 FDA 483 Weber Laboratories Inc - Form 483, 2003-10-09
November, 2010 FDA 483 Genlabs Corporation - Form 483, 2010-11-10
February, 2001 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2001-02-14
January, 2001 FDA 483 Mallinckrodt Inc - Form 483, 2001-01-23
May, 2013 EIR Genentech, Inc. - EIR, 2013-05-23
June, 2004 EIR Amphastar Pharmaceuticals, Inc. - EIR, 2004-06-10

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more